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Juhana Frösen1, Behnam Rezai Jahromi2, Juha Hernesniemi2emorrhage to the brain parenchyma is an important
cause of mortality and morbidity, causing a significantH economic burden related to loss of productive years
and health care costs1 in addition to human suffering.
REMOVAL OF HEMORRHAGIC MASS—IS THAT SUFFICIENT?
Intracerebral hemorrhage (ICH) 1) lacerates the brain paren-
chyma and disrupts white matter tracts; 2) causes mass effect
and disturbs the function of neighboring white matter tracts or
cortical regions; and 3) releases molecules that induce inflam-
mation and oxidative stress, which creates a tissue microenvi-
ronment that predisposes to death of neurons.2-4 Because of
the aforementioned deleterious effects of ICH, it would seem
logical that removal of ICH would reduce the degree of sec-
ondary parenchymal damage caused by mass effect and toxicity
of clot breakdown products. However, the neurologic impair-
ment left by the ICH is not only related to the mass effect but
also to the disruption of white matter tracts or destruction of
cortical regions, basal ganglia, thalamus, cerebellum, or brain-
stem during the acute bleeding. Moreover, it is unknown to
what extent the inflammation and oxidative stress triggered by
the presence of blood in the parenchyma affects the degree of
neuronal damage and outcome of the patient despite evacua-
tion of the blood clot. Experiments in animal models suggest
that pharmaceutical or other biologic therapy against the toxic
effects of clot-derived iron may improve the outcome of
patients with ICH.2-4 This suggests that the major improve-
ments in the management and outcome of patients with ICH
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Neurosurgeons know from experience and clinical series that
some patients benefit from removal of ICH, but others do not.
This situation is well demonstrated by the fact that guidelines
written by experts recommend consideration of surgery in
certain clinical scenarios of acute ICH despite the difficulty of
demonstrating the benefit in randomized clinical trials.5 How to
identify patients who truly benefit from ICH removal in the
long-term remains an unanswered challenge. Despite the large
number of studies published on the topic, further research is still
required, especially as the introduction of novel minimally inva-
sive surgical techniques6 may significantly reduce the risk of
causing additional neuronal injury with surgical approach.
TO USE MOTOR EVOKED POTENTIALS OR NOT IN ICH SURGERY—
IS THERE A BENEFIT?
Intraoperative use of motor evoked potentials (MEPs) to monitor
that the pyramidal tract stays intact during surgery is a widely
used and well-established technique that increases the safety of
many kinds of intracranial operations. The primary purpose
of intraoperative MEP monitoring is to alert the surgeon that his
or her actions are damaging the pyramidal tract so that the sur-
geon can alter his or her actions to avoid causing further injury.
The article by Ikedo et al. on the use of MEP monitoring during
ICH surgery is innovative, but it raises the question of clinical
utility. The authors state that in none of their cases did the MEPs
change during surgery, and they did not report that they would
have altered their surgical strategy or actions during the operation
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PERSPECTIVESfurther injury to the pyramidal tract during ICH removal, the main
determinant of functional outcome is the degree of damage
caused to the pyramidal tract by the hematoma itself, which is
what the results of Ikedo et al. also demonstrate. Similar con-
clusions are suggested by results of the International Surgical
Trial in Intracerebral Haemorrhage (STICH) trial, in which surgery
did not significantly improve functional outcome of survivors,7 as
well as by observations from a large population-based Finnish
ICH registry study, in which surgery for ICH reduced mortality but
did not significantly improve functional outcome of survivors.8
Because the surgeon avoids any transgression of the white
matter as much as possible during ICH surgery, with the
exception of sometimes having to coagulate a site of active
bleeding, it is not apparent how intraoperative MEP recordings
would change the surgical strategy—certainly one would not
leave a site of active bleeding unattended. The finding that MEP
measurements predict recovery of hemiparesis is not surpris-
ing; rather, it is the expected finding. How the ability to better
predict recovery of hemiparesis will improve clinical practice isWORLD NEUROSURGERY 91: 638-639, JULY 2016an open question to which the answer likely varies in different
societies and cultures. However, in most instances, one would
continue maximal rehabilitation and physical therapy in the
immediate postoperative period despite signs of severe damage
to the pyramidal tract. In a later phase, the clinical progression
of the hemiparesis will reveal the degree of injury to the pyra-
midal tract as well as the ability to recover without any MEP
recordings.
ICH AS A SURGICAL CHALLENGE—WHERE TO FOCUS?
Although it describes an innovative approach to study the use of
MEP monitoring during ICH removal, the article by Ikedo et al.
leaves open the question of what the benefit of MEP monitoring
would be. Instead of predicting functional outcome in the early
postoperative period, identification of patients who benefit from
surgery remains the main challenge in the treatment of ICH. In
addition, we should focus on the translation of the knowledge
learned from animal models of ICH into biologic therapies that
reduce the extent of ICH-induced neuronal injury in patients.REFERENCES
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